Dr. Leyland-Jones is a pre-eminent clinical trialist in oncology and the recipient of numerous awards.  He is the Chief Medical Officer of AIM-HI Accelerator Fund, OTraces, and the N OF 1 Mission.  In addition, he is a Scientific Advisory Board Member of the National Foundation for Cancer Research and NED Biosystems, Inc.  He is the CSO of The Darwin Foundation, collectively devoted to the implementation of prevention and cure of malignancy globally, and Director Emeritus for the WIN (Worldwide Innovative Networking in personalized cancer medicine) Consortium.